BSE: 530991 | NSE: | Pharmaceuticals & Drugs | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Roopa Industries Ltd is a below average quality company.
The key valuation ratios of Roopa Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Roopa Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -6.9% | 6.6% | 7% | 6.6% | 5.1% | 6.2% | 5.3% | 5.9% | 7.7% | 10.1% | - |
| Value Creation Index ⓘ | -1.5 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.6 | -0.6 | -0.5 | -0.3 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 28.6 | 31 | 30.6 | 29.9 | 18.9 | 30.2 | 27.7 | 28.6 | 51.2 | 76.2 | 66 |
| Sales YoY Gr. | - | 8.5% | -1.2% | -2.2% | -36.7% | 59.2% | -8.3% | 3.5% | 79% | 48.7% | - |
| Adj EPS ⓘ | -2.6 | 0.2 | 0.2 | 0.2 | 0.6 | 0.8 | 0.5 | 0.9 | 1.3 | 2 | 1.7 |
| YoY Gr. | - | NA | 15.8% | 9.1% | 133.3% | 35.7% | -38.2% | 93.6% | 46.2% | 51.9% | - |
| BVPS (₹) ⓘ | 10.8 | 11 | 11.2 | 11.9 | 12.5 | 13.3 | 13.7 | 14.7 | 16 | 17.7 | 19.1 |
| Adj Net Profit ⓘ | -2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.6 | 0.4 | 0.7 | 1.1 | 1.6 | 1 |
| Cash Flow from Ops. ⓘ | 0.7 | 0.6 | 1.3 | -1.2 | -4.5 | 4.4 | 2.4 | -0.5 | 2.3 | 8.9 | - |
| Debt/CF from Ops. ⓘ | 11.9 | 13.9 | 6.6 | -9.6 | -3.5 | 3.4 | 5.5 | -26.1 | 5.1 | 2.1 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 11.5% | 32.1% | 40.2% | 48.7% | ||||
| Adj EPS ⓘ | NA | 29.3% | 62.6% | 51.9% | ||||
| BVPSⓘ | 5.7% | 7.3% | 8.9% | 10.8% | ||||
| Share Price | 20.6% | 41% | 81.6% | 22.2% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -21.1 | 1.7 | 2 | 2.1 | 4.6 | 5.9 | 3.5 | 6.4 | 8.7 | 12 | 9 |
| Op. Profit Mgn % ⓘ | -0.7 | 6.9 | -2.8 | 7.5 | -13.9 | 8.3 | 6.6 | 9.5 | 6.8 | 5.6 | 6.2 |
| Net Profit Mgn % ⓘ | -7 | 0.5 | 0.6 | 0.6 | 2.3 | 2 | 1.4 | 2.5 | 2.1 | 2.1 | 2 |
| Debt to Equity ⓘ | 0.9 | 1 | 1 | 1.2 | 1.6 | 1.5 | 1.3 | 1.2 | 1 | 1.4 | - |
| Working Cap Days ⓘ | 176 | 176 | 190 | 215 | 440 | 308 | 342 | 394 | 255 | 191 | 122 |
| Cash Conv. Cycle ⓘ | 69 | 53 | 65 | 90 | 264 | 160 | 178 | 227 | 116 | 97 | 12 |
Sales growth is growing at healthy rate in last 3 years 40.18%
Net Profit is growing at healthy rate in last 3 years 62.59%
Return on Equity has declined versus last 3 years average to 9.00%
Debt to equity has increased versus last 3 years average to 1.35
Sales growth is not so good in last 4 quarters at -7.29%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 1.7 | - |
| TTM Sales (₹ Cr.) | 66.2 | - |
| BVPS (₹.) ⓘ | 19.1 | - |
| Reserves (₹ Cr.) ⓘ | 7 | - |
| P/BV ⓘ | 3.19 | - |
| PE ⓘ | 36.96 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 37.40 / 73.20 |
| All Time Low / High (₹) | 0.20 / 92.75 |
| Market Cap (₹ Cr.) | 47.8 |
| Equity (₹ Cr.) | 7.9 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 47.9 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.55 | 30.98 | 30.60 | 29.94 | 18.94 | 30.15 | 27.65 | 28.61 | 51.21 | 76.17 |
| Operating Expenses ⓘ | 28.74 | 28.85 | 31.47 | 27.71 | 21.56 | 27.65 | 25.82 | 25.89 | 47.77 | 72.28 |
| Manufacturing Costs | 5.13 | 5.03 | 5.62 | 4.69 | 2.34 | 2.90 | 4.02 | 3.40 | 3.99 | 5.24 |
| Material Costs | 19.82 | 20.50 | 23.06 | 18.62 | 15.55 | 22.71 | 17.59 | 17.35 | 39.86 | 61.48 |
| Employee Cost | 2.22 | 2.03 | 1.72 | 2.29 | 2.14 | 0.93 | 2.36 | 3.77 | 2.21 | 3.24 |
| Other Costs ⓘ | 1.58 | 1.29 | 1.07 | 2.10 | 1.53 | 1.10 | 1.84 | 1.37 | 1.72 | 2.32 |
| Operating Profit ⓘ | -0.19 | 2.12 | -0.86 | 2.24 | -2.63 | 2.50 | 1.83 | 2.72 | 3.44 | 3.89 |
| Operating Profit Margin (%) | -0.7% | 6.9% | -2.8% | 7.5% | -13.9% | 8.3% | 6.6% | 9.5% | 6.7% | 5.1% |
| Other Income ⓘ | 0.05 | 0.09 | 3.11 | 0.22 | 4.65 | 0.28 | 1.09 | 0.08 | 0.06 | 0.65 |
| Interest ⓘ | 1.22 | 1.36 | 1.46 | 1.52 | 1.05 | 1.42 | 1.36 | 1.06 | 1.21 | 1.84 |
| Depreciation ⓘ | 0.59 | 0.67 | 0.52 | 0.51 | 0.52 | 0.57 | 0.76 | 0.81 | 0.93 | 0.89 |
| Exceptional Items ⓘ | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | -1.95 | 0.18 | 0.26 | 0.43 | 0.44 | 0.79 | 0.80 | 0.93 | 1.36 | 1.81 |
| Tax ⓘ | 0.06 | 0.02 | 0.09 | 0.24 | -0.10 | 0.19 | 0.43 | 0.22 | 0.35 | 0.46 |
| Profit After Tax | -2.01 | 0.16 | 0.17 | 0.19 | 0.54 | 0.60 | 0.37 | 0.72 | 1.02 | 1.35 |
| PAT Margin (%) | -7.0% | 0.5% | 0.6% | 0.6% | 2.8% | 2.0% | 1.3% | 2.5% | 2.0% | 1.8% |
| Adjusted EPS (₹) | -2.6 | 0.2 | 0.2 | 0.2 | 0.7 | 0.8 | 0.5 | 0.9 | 1.3 | 1.7 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 8.49 | 8.65 | 8.82 | 9.36 | 9.82 | 10.42 | 10.80 | 11.56 | 12.58 | 13.94 |
| Share Capital ⓘ | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 | 7.87 |
| Reserves ⓘ | 0.62 | 0.79 | 0.96 | 1.50 | 1.95 | 2.56 | 2.93 | 3.70 | 4.72 | 6.08 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 7.49 | 8.08 | 7.73 | 10.51 | 14.90 | 13.46 | 12.24 | 12.46 | 10.47 | 18.02 |
| Long Term Debt | 2.69 | 3.40 | 4.90 | 7.02 | 10.05 | 9.48 | 7.36 | 7.83 | 4.10 | 1.68 |
| Short Term Debt | 4.81 | 4.69 | 2.83 | 3.49 | 4.85 | 3.98 | 4.88 | 4.63 | 6.36 | 16.34 |
| Trade Payables | 6.41 | 7.43 | 6.32 | 6.21 | 7.52 | 7.64 | 10.57 | 13.29 | 9.43 | 7.11 |
| Others Liabilities ⓘ | 1.47 | 1.35 | 2.40 | 2.72 | 3.08 | 4.95 | 4.58 | 9.02 | 16.54 | 17.47 |
| Total Liabilities ⓘ | 23.86 | 25.52 | 25.26 | 28.80 | 35.32 | 36.47 | 38.19 | 46.33 | 49.02 | 56.55 |
Fixed Assets | ||||||||||
| Gross Block | 12.73 | 12.39 | 11.84 | 12.17 | 12.23 | 12.43 | 17.42 | 18.06 | 18.32 | 19.45 |
| Accumulated Depreciation | 4.60 | 4.79 | 4.90 | 5.41 | 5.94 | 6.13 | 6.89 | 7.70 | 8.63 | 9.48 |
| Net Fixed Assetsⓘ | 8.13 | 7.60 | 6.94 | 6.76 | 6.29 | 6.30 | 10.53 | 10.36 | 9.69 | 9.98 |
| CWIP ⓘ | 0.02 | 0.04 | 0 | 0.03 | 2.39 | 4.49 | 0 | 0.10 | 0.69 | 0.88 |
| Investmentsⓘ | 0.04 | 0.04 | 0.04 | 0.16 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Inventories | 5.13 | 8.04 | 4.42 | 7.11 | 9.26 | 10.65 | 12.35 | 19.46 | 15.34 | 18.38 |
| Trade Receivables | 6.89 | 5.60 | 8.27 | 12.02 | 12.07 | 11.07 | 11.90 | 11.50 | 15.68 | 7.08 |
| Cash Equivalents | 0.56 | 0.67 | 0.73 | 0.71 | 0.60 | 0.75 | 0.73 | 1 | 2.01 | 2.73 |
| Others Assetsⓘ | 3.09 | 3.53 | 4.86 | 2.01 | 4.68 | 3.19 | 2.67 | 3.91 | 5.61 | 17.49 |
| Total Assets ⓘ | 23.86 | 25.52 | 25.26 | 28.80 | 35.32 | 36.47 | 38.19 | 46.33 | 49.02 | 56.55 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 0.66 | 0.60 | 1.27 | -1.17 | -4.53 | 4.42 | 2.44 | -0.52 | 2.34 | 8.91 |
| PBT ⓘ | -1.95 | 0.18 | 0.26 | 0.43 | 0.44 | 0.79 | 0.80 | 0.93 | 1.36 | 1.81 |
| Adjustment ⓘ | 1.77 | 1.95 | 1.89 | 2.10 | -3.14 | 1.68 | 0.99 | -0.19 | -2.33 | 2.09 |
| Changes in Working Capital ⓘ | 0.89 | -1.53 | -0.88 | -3.64 | -1.71 | 2.14 | 1.08 | -1.04 | 3.66 | 5.47 |
| Tax Paid ⓘ | -0.05 | 0 | 0 | -0.06 | -0.12 | -0.19 | -0.43 | -0.22 | -0.35 | -0.46 |
| Cash Flow From Investing Activity ⓘ | -0.26 | -0.13 | 0.19 | -0.45 | 2.50 | -2.43 | 0.70 | 1.34 | 3.65 | -0.99 |
| Capex | -0.28 | -0.16 | 0.18 | -0.37 | -2.42 | -2.68 | -0.50 | -0.74 | -0.84 | -1.37 |
| Net Investments | 0 | 0 | 0 | -0.09 | 0.27 | -0.03 | 0.11 | -0.03 | -0.02 | -0.27 |
| Others ⓘ | 0.01 | 0.03 | 0.01 | 0.01 | 4.65 | 0.28 | 1.09 | 2.11 | 4.52 | 0.65 |
| Cash Flow From Financing Activityⓘ | -0.41 | -0.40 | -1.49 | 1.56 | 2.05 | -1.88 | -3.06 | -0.58 | -5.01 | -7.47 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | -1.22 | -1.35 | -1.46 | -1.52 | -1.05 | -1.39 | -1.31 | -1.05 | -1.26 | -1.84 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0.81 | 0.95 | -0.03 | 3.07 | 3.11 | -0.49 | -1.75 | 0.48 | -3.75 | -5.63 |
| Net Cash Flow ⓘ | -0.02 | 0.08 | -0.02 | -0.07 | 0.02 | 0.11 | 0.08 | 0.25 | 0.99 | 0.45 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -21.14 | 1.88 | 1.96 | 2.07 | 5.63 | 5.97 | 3.51 | 6.41 | 8.41 | 10.17 |
| ROCE (%) | -4.35 | 9.25 | 10.06 | 10.27 | 6.44 | 8.63 | 8.67 | 8.06 | 10.37 | 12.73 |
| Asset Turnover Ratio | 1.29 | 1.36 | 1.31 | 1.21 | 0.61 | 0.84 | 0.74 | 0.68 | 1.07 | 1.44 |
| PAT to CFO Conversion(x) | N/A | 3.75 | 7.47 | -6.16 | -8.39 | 7.37 | 6.59 | -0.72 | 2.29 | 6.6 | Working Capital Days |
| Receivable Days | 84 | 68 | 76 | 113 | 225 | 140 | 152 | 149 | 97 | 55 |
| Inventory Days | 62 | 72 | 68 | 64 | 153 | 121 | 152 | 203 | 124 | 81 |
| Payable Days | 110 | 123 | 109 | 123 | 161 | 122 | 189 | 251 | 104 | 49 |
Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.
Roopa Industries is a chemical industry, growing in terms of its turn-over & profit making and reliability & credibility. Proud suppliers to several prestigious companies and exports to Germany, Netherlands, Srilanka etc.
The facility of the company comprises of the plant and equipment to carry out versatile operations for various reactions and related processes with an aggregate capacity of 60 Kilo Litres supported by utilities to meet chilling requirements of up to -25 Deg C and heating requirements of 500 Deg C coupled with requisite vacuums up to even one Torr and distillations.
The company has successfully handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.
Product range of the company includes:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
